TITLE

Merkley joins with Omnicom sibling

AUTHOR(S)
Goetzl, David; Snyder, Beth
PUB. DATE
November 1999
SOURCE
Advertising Age;11/8/1999, Vol. 70 Issue 46, p128
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
This article focuses on the merger between marketing services firms Merkley Newman Harty and Consumer Healthworks in 1999. The merger, effective January, 2000, was formed to allow the companies to enter the direct-to-consumer (DTC) pharmaceutical advertising market. Prior to the merger, Consumer Healthworks managed accounts from companies such as Bristol-Myers Squibb Co. Anne Devereux, the president of Consumer Healthworks said that DTC advertising will enable the company to compete with the major brands.
ACCESSION #
2462684

 

Related Articles

  • DDR on DTC. Dick-Rath, Deborah // Medical Marketing & Media;Jun2012, Vol. 47 Issue 6, p26 

    The article reports on the application of animation in a direct-to-consumer (DTC) campaign for Abilify, an add-on treatment for depression from Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. Ltd.

  • BMS marketing, ad expenditures up 7%. Arnold, Matthew // Medical Marketing & Media;Dec2005, Vol. 40 Issue 12, p11 

    The article reports that pharmaceutical company Bristol-Myers Squibb Co. has raised its marketing and advertising expenditures by 7% in the third quarter of 2005. This rise is chiefly based on expanded DTC advertising for Plavix, the launch of Baraclude and its first-ever print advertising...

  • Aiming to stay No. 1. Sanders, Lisa; Goetzl, David // Advertising Age;12/10/2001, Vol. 72 Issue 50, p4 

    The article focuses on the marketing strategy used by pharmaceutical company Pfizer for the promotion of its cholesterol-lowering drug Lipitor. The advertising campaign developed by Omnicom Group's Merkley Newman Harty and Partners, is designed to maintain Lipitor's dominance in the statin category.

  • FDA actions benefit DTC.  // Advertising Age;8/18/2003, Vol. 74 Issue 33, p16 

    The editorial explains why direct-to-consumer (DTC) drug makers should support the U.S. Food and Drug Administration's (FDA) regulation of their advertisements. It cites the importance of credible advertising regulation for the DTC industry in light of the FDA case against the advertisements for...

  • FDA holds hearing for DTC guidelines. Thomaselli, Rich // Advertising Age;9/22/2003, Vol. 74 Issue 38, p3 

    The article reports on a public meeting conducted by the U.S. Food and Drug Administration (FDA) to hear both sides of the direct-to-consumer (DTC) advertising argument before issuing new guidelines for the pharmaceutical industry. The FDA is concerned that the drug companies are not presenting...

  • Flying the friendly skies? Get real, say these hardened road warriors. Capps, Brooke // Advertising Age;3/12/2007, Vol. 78 Issue 11, p38 

    The article discusses U.S. business airline travel. According to the U.S. Bureau of Transportation Statistics, airline passengers logged more than 800 billion miles in 2006. The top travel complaints from U.S. business passengers include intrusive security procedures, cramped seating and...

  • FDA wedged between a rock and a hard place in DTC debate. Thomaselli, Rich // Advertising Age;11/7/2005, Vol. 76 Issue 45, p1 

    This article analyzes the efforts of the U.S. Food and Drug Administration (FDA) to resolve issues surrounding direct-to-consumer (DTC) pharmaceutical advertising. In theory, what the FDA is trying to do is to satisfy supporters of a $4 billion industry while at the same time, address the...

  • Accounts & Action.  // Pharmaceutical Executive;Dec99, Vol. 19 Issue 12, p59 

    Presents a list of healthcare industries in the United States. Consumer Healthworks company; Merkley Newman Harty company; Dudnyk Healthcare Group company.

  • Acquisitions latest DTC side effect. Goetzl, David; Petrecca, Laura; Snyder, Beth // Advertising Age;11/15/1999, Vol. 70 Issue 47, p16 

    This article focuses on the mergers and acquisitions trend in the healthcare advertising business as of November 1999. For reasons ranging from consolidation of the pharmaceutical industry to the boom in direct-to-consumer advertising of prescription drugs, large consumer advertising agencies...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics